VÖOST

Australian brand of effervescent vitamins and supplements targeting Millennial and Gen-Z consumers.

Cover Block

Open sources

Field	Value
Name	VÖOST
Tagline	Australian brand of effervescent vitamins and supplements targeting Millennial and Gen-Z consumers [William Hood & Company, accessed 2026]
Headquarters	Melbourne, Australia
Founded	2013 [SmartCompany, July 2016]
Stage	Exited [Australian Financial Review, April 2021]
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology	No Technology Component
Geography	Oceania
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+) [SmartCompany, July 2016]
Funding Label	Unknown

What an Investor Needs First

PUBLIC VÖOST is an Australian effervescent vitamins and supplements brand that merits attention because it appears to have built meaningful category share quickly and then exited to Procter & Gamble in 2021, a credible signal that strategic buyers saw value in its shelf presence and consumer positioning [SmartCompany, July 2016] [Australian Financial Review, April 2021]. The founding story is relatively straightforward in the public record: the business was founded in 2013 as VitaminHaus, with Thomas Siebel identified as co-founder and managing director, and was initially built to bring a broad range of effervescent vitamin products to the Australian market [SmartCompany, July 2016]. Its product thesis was less about technical novelty than merchandising and brand architecture, positioning effervescent tablets as a more consumer-oriented, digitally marketed alternative to traditional vitamin products, later described as targeting Millennial and Gen-Z wellness buyers [SmartCompany, July 2016] [William Hood & Company].

The early traction claims are notable, if only partially corroborated. SmartCompany reported that by 2016 the brand had reached a 35% share of Australia’s effervescent-vitamin market and roughly $5 million in brand value, while later reporting pointed to almost 3,000 stockists across Australia, suggesting broad offline distribution alongside the direct-to-consumer narrative [SmartCompany, July 2016] [SmartCompany, April 2021]. On team quality, the public evidence is strongest around Siebel, who was described as a former managing director of Sakata in Australia and later identified elsewhere as a former Coles executive, while co-founder Jason Scher is also publicly linked to the business [SmartCompany, July 2016] [SmartCompany, April 2021] [EO Melbourne, September 2018].

Funding history is thin in public datasets, and no confirmed venture rounds are surfaced in the available source set, which makes this read more like a brand-building consumer company that achieved a strategic exit than a transparently venture-financed startup [Crunchbase] [CB Insights]. The business model is clearest as consumer packaged goods sold direct to consumers and through retail stockists, with differentiation resting on branding, formulation breadth, and channel execution rather than proprietary technology [SmartCompany, July 2016] [Healthcare Market Experts]. Over the next 12 to 18 months, if this were being diligenced as a historical case rather than an active financing, the main points to watch would be how much of the 2021 acquisition case was driven by durable consumer pull versus endorsement-led acceleration, and whether the brand’s reported market share translated into category leadership that survived inside a large strategic owner [Australian Financial Review, April 2021].

Partially corroborated -- This section relies primarily on SmartCompany, Australian Financial Review, William Hood & Company, and public profile databases; several core claims are supported by single-source reporting rather than broad independent corroboration.

Taxonomy Snapshot

Axis	Value
Stage	Exited
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Technology Type	No Technology Component
Geography	Oceania
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)

Inside the Company

PUBLIC

The public record on VÖOST is thin, and that matters because the core company profile needs to be kept narrower than the brand story. Crunchbase identifies VÖOST as a company based in Melbourne, Australia, founded in 2013 [Crunchbase]. That aligns with the brand’s own later-case-study framing that places the business in Australia and describes VÖOST as the consumer brand built from that base [William Hood & Company, accessed 2026].

The chronology that can be supported from company-linked sources is straightforward. VÖOST was founded in 2013 and grew as an Australian consumer supplements brand before its 2021 sale to Procter & Gamble, according to the company case study and Crunchbase profile [William Hood & Company, accessed 2026] [Crunchbase]. The same case study states that the business began as VitaminHaus, with VÖOST operating as the consumer-facing brand, but the legal entity name is not otherwise corroborated in the source set used for this section [William Hood & Company, accessed 2026].

Partially corroborated -- Based primarily on Crunchbase, with partial corroboration from a company case study.

Under the Hood

MIXED

VÖOST’s product is straightforward to describe, which is useful here because the public record is thinner on formulation detail than on brand positioning. The company sells effervescent vitamins and supplements in tablet form in Australia, and the early wedge was breadth of assortment inside that format rather than a software or device layer [SmartCompany, July 2016] [Healthcare Market Experts]. SmartCompany described the brand in 2016 as a consumer-oriented, digitally marketed alternative to more traditional vitamin products, while later case-study material positioned it toward Millennial and Gen-Z wellness consumers [SmartCompany, July 2016] [William Hood & Company].

The product claims that do surface are mostly around range and ingredient positioning, and they should be read as company-adjacent claims rather than independently tested differentiation. VÖOST’s Facebook presence says it offers the widest range of effervescent vitamins in Australia, and LinkedIn profile references describe the line as developed by a leading naturopath in Australia, with products framed as “better for you” because they are free from artificial colors, preservatives, and flavors [Facebook] [LinkedIn, Steven Ivak, accessed 2026]. Those sources help explain shelf appeal and brand narrative, but they do not establish clinical performance, proprietary formulation IP, or a distinct technology stack. On the evidence available, this is best understood as a branded consumer health product business with digital marketing strength, not a technology company despite the report taxonomy slot [SmartCompany, July 2016] [William Hood & Company].

Partially corroborated -- Product format and positioning are supported by SmartCompany and William Hood & Company, while formulation and range claims rely on company-adjacent social and LinkedIn sources.

Market Research

PUBLIC This market matters because VÖOST’s early traction sat at the intersection of three durable consumer behaviors, preventive wellness spending, convenience-led supplement formats, and brand discovery through digital channels, but the public record here is thinner on formal market sizing than on product-market fit signals [SmartCompany, July 2016] [William Hood & Company, accessed 2026].

There is no cited third-party TAM, SAM, or SOM model in the source set for Australian effervescent vitamins specifically, so the cleaner approach is to stay with observed market-position evidence rather than force an unsupported sizing exercise. The strongest public signal is SmartCompany’s 2016 report that VÖOST had reached 35% of Australia’s effervescent-vitamin market, alongside approximately $5 million in brand value at that time [SmartCompany, July 2016]. That does not establish the size of the total vitamin market, but it does indicate a meaningful position inside a narrower format-led category where consumer attention can concentrate quickly.

Demand drivers are easier to see than market boundaries. VÖOST was positioned as a consumer-oriented, digitally marketed alternative to traditional vitamin products, and later case-study material described the brand as aimed at Millennial and Gen-Z health-and-wellness consumers [SmartCompany, July 2016] [William Hood & Company, accessed 2026]. That matters because effervescent tablets sit in a practical middle ground between conventional pills and functional beverages: they retain supplement economics while offering a more approachable user experience for younger buyers who respond to format, taste, and branding as much as ingredient lists [Healthcare Market Experts] [William Hood & Company, accessed 2026].

The adjacent markets are broader than the company category label suggests. VÖOST competes not only with other vitamin tablets, but also with chewables, gummies, powdered drink mixes, hydration products, and everyday wellness beverages that serve similar consumer jobs, namely routine supplementation and convenient daily health habits [SmartCompany, July 2016] [Healthcare Market Experts]. This substitute set likely expands the addressable purchase occasions, but it also means the brand was operating in a shelf and screen environment where differentiation rests on formulation range, packaging, retail visibility, and consumer-brand recall rather than on proprietary technology.

Macro and regulatory forces are relevant even if the source set does not surface detailed compliance analysis. As an ingestible consumer-health product, VÖOST sits in a category where claims discipline, ingredient transparency, and retailer trust matter, especially when the brand promise leans on being "better for you" and free from certain artificial additives according to LinkedIn-sourced product descriptions [LinkedIn, Steven Ivak, accessed 2026]. At the same time, the 2021 acquisition by Procter & Gamble suggests that scaled consumer-health incumbents saw strategic value in premium supplement brands with established distribution and resonance among younger consumers, a useful signal for category maturity even without disclosed transaction terms [Australian Financial Review, April 2021] [Business News Australia].

Cited market signal	Figure	Source
Share of Australia effervescent-vitamin market	35%	[SmartCompany, July 2016]
Brand value	$5 million	[SmartCompany, July 2016]
Stockists across Australia	Almost 3,000	[SmartCompany, April 2021]

The table is less a sizing model than a market-read shortcut. Public evidence supports a strong niche position in a defined supplement format, but not a full top-down market map, so any underwriting of category expansion should remain conditional on external category data beyond the current record.

Partially corroborated -- This section relies primarily on SmartCompany reporting, with partial support from William Hood & Company, Australian Financial Review, Business News Australia, and product-format descriptions from Healthcare Market Experts and LinkedIn-sourced materials.

Competition and Substitutes

MIXED VÖOST appears to have competed less as a novel formulation business than as a branded route to younger vitamin buyers, which means its real alternatives were incumbent supplement aisles, other effervescent formats, and adjacent wellness products competing for the same consumer attention and shelf space [SmartCompany, July 2016] [William Hood & Company, accessed 2026].

The public record here is thin on named direct rivals, so the cleanest way to read the field is by competitive layer rather than by a verified list of logos. At one end sat traditional vitamin products, the category VÖOST explicitly positioned against through consumer-facing branding and digital marketing [SmartCompany, July 2016]. At another sat effervescent products as a format, where SmartCompany reported VÖOST had reached a 35% share of Australias effervescent-vitamin market by 2016, suggesting the company had already carved out meaningful space within that narrower subsegment even if public sources do not identify the brands on the other side of that share split [SmartCompany, July 2016].

That distinction matters because the strongest incumbents were likely not startup challengers but established supplement brands with broader retail relationships, more SKUs across formats, and larger marketing budgets, while adjacent substitutes included gummies, capsules, powders, and functional wellness products sold through the same pharmacies, grocers, and e-commerce pathways. Public sources support VÖOSTs effort to make vitamins feel more consumer-branded and youth-oriented, not a claim that it owned a proprietary technology or regulatory barrier [SmartCompany, July 2016] [Healthcare Market Experts] [William Hood & Company, accessed 2026].

The best evidence for a defensible edge is distribution plus brand fit. By 2016, SmartCompany reported almost 3,000 stockists across Australia and a 35% share of the domestic effervescent-vitamin market, while William Hood & Company later described the brand as an Australian pioneer aimed at Millennial and Gen-Z wellness consumers [SmartCompany, April 2021] [SmartCompany, July 2016] [William Hood & Company, accessed 2026]. That combination, shelf presence and audience-specific positioning, can be durable for a period, but it is also perishable because it depends on continued retailer support and brand relevance rather than on patents, software, or switching costs.

VÖOST also appears to have benefited from founder-level consumer packaged goods experience rather than from venture-style product defensibility. SmartCompany identified co-founder and managing director Thomas Siebel as a former managing director of Sakata rice crackers in Australia, and later reporting tied the brand to a high-visibility endorsement push around Dustin Martin before the 2021 sale to Procter & Gamble [SmartCompany, July 2016] [Australian Financial Review, April 2021]. In plain terms, the edge looks commercial: packaging, placement, marketing, and retail execution. Those advantages can scale quickly, but they are easier for a larger owner or a well-funded incumbent to replicate than a protected formulation platform would be.

The main exposure follows directly from that. A large supplement incumbent with stronger pharmacy and grocery relationships could likely match VÖOST on shelf access, widen assortment beyond effervescent tablets, and outspend it on consumer marketing, while adjacent wellness brands could compete for the same younger buyer without being limited to the effervescent format. Public evidence does not show that VÖOST owned a channel outright, held exclusive retail access, or had a technical moat around its products [SmartCompany, July 2016] [Facebook] [LinkedIn, accessed 2026]. That leaves the company most exposed where category power shifts from branding to portfolio breadth.

Over an 18-month competitive window, the most plausible scenario is bifurcation rather than winner-take-all. VÖOST would be the likely winner if consumer demand continued shifting toward branded, convenient, better-for-you vitamin formats and if retail partners kept rewarding velocity in the effervescent niche [SmartCompany, July 2016] [LinkedIn, accessed 2026]. Traditional vitamin incumbents would be the likely losers if younger consumers kept migrating away from legacy presentation and brand cues, but VÖOST itself would be vulnerable if broader supplement groups treated effervescents as a line extension and used superior distribution to compress the niche it helped popularize.

Partially corroborated -- This section relies primarily on SmartCompany and William Hood & Company for category positioning, with limited independent public naming of direct competitors and no verified competitor list in the supplied sources.

Opportunity

PUBLIC The size of the prize here was never software-style recurring revenue, but something simpler and still meaningful: if VÖOST could become the default modern effervescent-vitamin brand for younger consumers in Australia and then travel through a global consumer-health distribution system, the upside was a strategic consumer-health exit rather than a niche supplement outcome [SmartCompany, July 2016] [William Hood & Company].

The headline opportunity was brand leadership in a format category that looked underdeveloped, then strategically scarce. By 2016, SmartCompany reported that VÖOST had reached a 35% share of Australia’s effervescent-vitamin market, alongside approximately $5 million in brand value, only a few years after founding in 2013 [SmartCompany, July 2016]. That matters because the evidence suggests VÖOST was not trying to outspend incumbents across all vitamins. It was concentrating on effervescent tablets, packaging the proposition as a consumer-oriented, digitally marketed alternative to traditional vitamin products, and aiming it at Millennial and Gen-Z buyers who were less attached to legacy supplement brands [SmartCompany, July 2016] [William Hood & Company]. In consumer health, that is often the reachable path to an outsized outcome: own a subcategory first, then let a strategic buyer decide the format can be rolled into a larger shelf and media machine. Procter & Gamble’s acquisition in 2021 is the clearest public signal that this was reachable rather than theoretical [Australian Financial Review, April 2021] [Business News Australia].

The growth paths were not infinite, but they were legible enough to map.

Scenario	What happens	Catalyst	Why it's plausible
Own the Australian effervescent aisle	VÖOST turns format leadership into sustained category control across grocery, pharmacy, and mass retail in Australia	Early market-share leadership in a fragmented format category	SmartCompany reported 35% share of Australia’s effervescent-vitamin market in 2016 and almost 3,000 stockists nationally by 2016, which points to both consumer pull and physical distribution reach [SmartCompany, July 2016] [SmartCompany, April 2021]
Become the youth-oriented supplement brand that strategics need	VÖOST extends beyond tablets into a broader wellness brand built for Millennial and Gen-Z consumers, then becomes a portfolio fit for a multinational acquirer	Brand positioning that differs from traditional supplement marketing	Public materials describe VÖOST as a digitally marketed, consumer-oriented alternative aimed at younger health-and-wellness consumers, a positioning that large consumer groups often buy rather than build [SmartCompany, July 2016] [William Hood & Company]
Use strategic distribution to internationalize the format	After establishing domestic brand proof, VÖOST uses acquirer infrastructure to expand beyond Australia	Acquisition by a global consumer products company with established international channels	William Hood & Company states that Procter & Gamble acquired VÖOST in 2021, which supports the view that the brand had attributes transferable into a larger distribution system [William Hood & Company] [Australian Financial Review, April 2021]

What compounding looks like in this model is distribution and brand reinforcement rather than a software network effect. A supplement brand that wins younger consumers can improve shelf placement, retail density, and repeat purchase at the same time, and each of those can lower the cost of the next account or campaign. The public evidence is limited, but the sequence is visible: VÖOST built a digitally marketed identity around a distinct dosage format, reached broad national stockist coverage, and later used higher-profile marketing, including reported endorsement by Dustin Martin, to accelerate sales ahead of the Procter & Gamble deal [SmartCompany, July 2016] [SmartCompany, April 2021] [Australian Financial Review, April 2021]. That is a recognizable consumer flywheel, product differentiation creates trial, retail presence creates habit, and brand visibility makes the next retail conversation easier.

The size of the win is best framed through the actual strategic outcome rather than unsupported venture arithmetic. Procter & Gamble acquired VÖOST in 2021, although public sources in this record do not disclose the purchase price [Australian Financial Review, April 2021] [William Hood & Company]. With no confirmed valuation, the cleanest public interpretation is that the company reached the threshold where a global consumer-health buyer viewed the brand, format focus, and distribution traction as worth owning. If the "Own the Australian effervescent aisle" scenario had continued to play out independently, the plausible end-state would still have been a strategic sale into a larger consumer platform rather than a standalone public company, with value ultimately tied to category leadership, retail breadth, and brand resonance among younger buyers (scenario, not a forecast) [SmartCompany, July 2016] [William Hood & Company].

Partially corroborated -- This section relies primarily on SmartCompany, Australian Financial Review, Business News Australia, and William Hood & Company, with several material claims supported by a single public source and no disclosed acquisition price.

Sources